Review

. 2020 Nov;38(4):601-617.

doi: 10.1016/j.ccl.2020.07.005. Epub 2020 Sep 17.

MicroRNAs and Long Noncoding RNAs in Coronary Artery Disease: New and Potential Therapeutic Targets

Lukasz Zareba¹, Alex Fitas¹, Marta Wolska¹, Eva Junger¹, Ceren Eyileten¹, Zofia Wicik², Salvatore De Rosa³, Jolanta M Siller-Matula⁴, Marek Postula⁵

Affiliations

¹ Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Banacha 1B Str., Warsaw 02-097, Poland.
² Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Banacha 1B Str., Warsaw 02-097, Poland; Centro de Matemática, Computação e Cognição, Universidade Federal do ABC, Alameda da Universidade, s/n-Anchieta, São Paulo 09606-045, Brazil.
³ Division of Cardiology, Department of Medical and Surgical Sciences, "Magna Graecia" University, Viale Europa, Catanzaro 88100, Italy.
⁴ Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Banacha 1B Str., Warsaw 02-097, Poland; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Spitalgasse 23, Vienna 1090, Austria.
⁵ Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Banacha 1B Str., Warsaw 02-097, Poland; Longevity Center, Warsaw, Poland. Electronic address: mpostula@wum.edu.pl.

PMID: 33036721
DOI: 10.1016/j.ccl.2020.07.005

Review

MicroRNAs and Long Noncoding RNAs in Coronary Artery Disease: New and Potential Therapeutic Targets

Lukasz Zareba et al. Cardiol Clin. 2020 Nov.

. 2020 Nov;38(4):601-617.

doi: 10.1016/j.ccl.2020.07.005. Epub 2020 Sep 17.

Authors

Lukasz Zareba¹, Alex Fitas¹, Marta Wolska¹, Eva Junger¹, Ceren Eyileten¹, Zofia Wicik², Salvatore De Rosa³, Jolanta M Siller-Matula⁴, Marek Postula⁵

Affiliations

¹ Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Banacha 1B Str., Warsaw 02-097, Poland.
² Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Banacha 1B Str., Warsaw 02-097, Poland; Centro de Matemática, Computação e Cognição, Universidade Federal do ABC, Alameda da Universidade, s/n-Anchieta, São Paulo 09606-045, Brazil.
³ Division of Cardiology, Department of Medical and Surgical Sciences, "Magna Graecia" University, Viale Europa, Catanzaro 88100, Italy.
⁴ Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Banacha 1B Str., Warsaw 02-097, Poland; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Spitalgasse 23, Vienna 1090, Austria.
⁵ Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Center for Preclinical Research and Technology CEPT, Banacha 1B Str., Warsaw 02-097, Poland; Longevity Center, Warsaw, Poland. Electronic address: mpostula@wum.edu.pl.

PMID: 33036721
DOI: 10.1016/j.ccl.2020.07.005

Abstract

Noncoding RNAs (ncRNAs), including long noncoding RNAs and microRNAs, play an important role in coronary artery disease onset and progression. The ability of ncRNAs to simultaneously regulate many target genes allows them to modulate various key processes involved in atherosclerosis, including lipid metabolism, smooth muscle cell proliferation, autophagy, and foam cell formation. This review focuses on the therapeutic potential of the most important ncRNAs in coronary artery disease. Moreover, various other promising microRNAs and long noncoding RNAs that attract substantial scientific interest as potential therapeutic targets in coronary artery disease and merit further investigation are presented.

Keywords: Atherosclerosis; Long noncoding RNA; lncRNAs; miR-155; miR-33; miR-92a; miRNAs; microRNA.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The authors state there are no conflicts of interest. Acknowledgments The article was published as a result of the collaboration within the I-COMET team.

Cited by

Identifying Candidate Circulating RNA Markers for Coronary Artery Disease by Deep RNA-Sequencing in Human Plasma.
Ward Z, Schmeier S, Pearson J, Cameron VA, Frampton CM, Troughton RW, Doughty RN, Richards AM, Pilbrow AP. Ward Z, et al. Cells. 2022 Oct 11;11(20):3191. doi: 10.3390/cells11203191. Cells. 2022. PMID: 36291058 Free PMC article.
Expression of miR-223 to predict outcomes after transcatheter aortic valve implantation.
Eyileten C, Skrobucha A, Starczyński M, Boszko M, Jarosz-Popek J, Fitas A, Filipiak KJ, Kochman J, Huczek Z, Rymuza B, Wilimski R, Kuśmierczyk M, Siller-Matula JM, Postula M, Gąsecka A. Eyileten C, et al. Cardiol J. 2024;31(1):111-123. doi: 10.5603/CJ.a2022.0090. Epub 2022 Oct 6. Cardiol J. 2024. PMID: 36200549 Free PMC article.
Altered Circulating MicroRNA Profiles After Endurance Training: A Cohort Study of Ultramarathon Runners.
Eyileten C, Wicik Z, Fitas A, Marszalek M, Simon JE, De Rosa S, Wiecha S, Palatini J, Postula M, Malek LA. Eyileten C, et al. Front Physiol. 2022 Jan 25;12:792931. doi: 10.3389/fphys.2021.792931. eCollection 2021. Front Physiol. 2022. PMID: 35145424 Free PMC article.
Potential Involvement of LncRNAs in Cardiometabolic Diseases.
Ilieva M, Uchida S. Ilieva M, et al. Genes (Basel). 2023 Jan 13;14(1):213. doi: 10.3390/genes14010213. Genes (Basel). 2023. PMID: 36672953 Free PMC article. Review.
Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19.
Eyileten C, Wicik Z, Simões SN, Martins-Jr DC, Klos K, Wlodarczyk W, Assinger A, Soldacki D, Chcialowski A, Siller-Matula JM, Postula M. Eyileten C, et al. RNA Biol. 2022 Jan;19(1):963-979. doi: 10.1080/15476286.2022.2100629. RNA Biol. 2022. PMID: 35938548 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

MicroRNAs and Long Noncoding RNAs in Coronary Artery Disease: New and Potential Therapeutic Targets

Affiliations

MicroRNAs and Long Noncoding RNAs in Coronary Artery Disease: New and Potential Therapeutic Targets

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Abstract

Conflict of interest statement

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical